In a response to a lawsuit filed in June, the agency has pledged to approve additional federal cultivation licenses from a pool of applications that have been pending for nearly three years. The Drug Enforcement Administration (DEA) announced Aug. 26 that it will take steps to expand the scientific and medical research of cannabis, pledging to approve additional federal cultivation licenses from a pool of applications that have been pending since 2016. The agency submitted a filing in the Fede...
Browse Article Categories
Segra International to Be a Lead Genetics Partner in Shoppers Drug Mart and TruTrace Technologies Pilot Traceability Program for Medical Cannabis
Rate this article
No Comments Yet
Be the first to share what you think!